Trials / Sponsors / Inhatarget Therapeutics
Inhatarget Therapeutics
Industry · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung NSCLC (advanced Non-small Cell Lung Cancer), Stage IV Lung Cancer | Phase 1 / Phase 2 | 2023-06-23 |